Literature DB >> 9658065

Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease.

D Kaplan1, S Sieg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9658065      PMCID： PMC109763     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  69 in total

1.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.

Authors:  P Klenerman; S Rowland-Jones; S McAdam; J Edwards; S Daenke; D Lalloo; B Köppe; W Rosenberg; D Boyd; A Edwards
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

2.  High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children.

Authors:  K M Debatin; A Fahrig-Faissner; S Enenkel-Stoodt; W Kreuz; A Benner; P H Krammer
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

3.  The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.

Authors:  R Gehri; S Hahn; M Rothen; M Steuerwald; R Nuesch; P Erb
Journal:  AIDS       Date:  1996-01       Impact factor: 4.177

4.  Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis.

Authors:  R C Marcellus; J G Teodoro; T Wu; D E Brough; G Ketner; G C Shore; P E Branton
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product.

Authors:  M Dobbelstein; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children.

Authors:  C B Bäumler; T Böhler; I Herr; A Benner; P H Krammer; K M Debatin
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

7.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

8.  Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells?

Authors:  P Biswas; G Poli; J M Orenstein; A S Fauci
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  Induction of apoptosis by baculovirus transactivator IE1.

Authors:  E A Prikhod'ko; L K Miller
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease.

Authors:  L Meyaard; S A Otto; I P Keet; M T Roos; F Miedema
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808
View more
  16 in total

Review 1.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 2.  Viruses and apoptosis.

Authors:  B J Thomson
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

3.  Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery.

Authors:  A E Sousa; A F Chaves; M Doroana; F Antunes; R M Victorino
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  Reovirus-induced apoptosis is mediated by TRAIL.

Authors:  P Clarke; S M Meintzer; S Gibson; C Widmann; T P Garrington; G L Johnson; K L Tyler
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 5.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

6.  Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.

Authors:  M Paiardini; D Galati; B Cervasi; G Cannavo; L Galluzzi; M Montroni; D Guetard; M Magnani; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2.

Authors:  Hayley Ipp; Bongani B Nkambule; Timothy D Reid; Dalene de Swardt; Linda-Gail Bekker; Richard H Glashoff
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

8.  Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death.

Authors:  Min Li-Weber; Markus A Weigand; Marco Giaisi; Dorothee Süss; Monika K Treiber; Sven Baumann; Elena Ritsou; Raoul Breitkreutz; Peter H Krammer
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Increased Fas-mediated apoptosis in polymorphonuclear cells from HIV-infected patients.

Authors:  S Salmen; G Terán; L Borges; L Goncalves; B Albarrán; H Urdaneta; H Montes; L Berrueta
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.